Mannan-binding lectin in malignancy
Copyright policy )Mannan-binding lectin in malignancy
Complement may play a dual role in cancer: it may contribute either to the development or to the inhibition of tumour growth. Its components may be candidate biomarkers facilitating the disease detection, its progress or effectiveness of therapy. Additionally, complement deficiencies may increase the risk of infections and contribute to the higher mortality, especially in patients undergoing aggressive chemotherapy. In this paper, possible cancer associations of one of the factors activating complement via the lectin pathway, mannan-binding lectin (MBL), are discussed.
- Scottish National Blood Transfusion Service United Kingdom
- Polish Academy of Learning Poland
- Polish Academy of Sciences Poland
- Institute for Medical Biology Poland
Neoplasms, Animals, Humans, Complement Pathway, Mannose-Binding Lectin, Protein Multimerization, Medical Oncology, Mannose-Binding Lectin, Models, Biological
Neoplasms, Animals, Humans, Complement Pathway, Mannose-Binding Lectin, Protein Multimerization, Medical Oncology, Mannose-Binding Lectin, Models, Biological
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).22 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!